Evidence map›Paper›PMID 37254128›Full record

ArticleMolecular neurodegeneration2023

Correction: Mutations in α-synuclein, TDP-43 and tau prolong protein half-life through diminished degradation by lysosomal proteases.

Paul J Sampognaro, Shruti Arya, Giselle M Knudsen, Emma L Gunderson, Angelica Sandoval-Perez, Molly Hodul, Kathryn Bowles, Charles S Craik, Matthew P Jacobson, Aimee W Kao

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular neurodegeneration, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Paul J SampognaroMemory and Aging Center, Department of Neurology, University of California, San Francisco, CA, USA.
Shruti AryaMemory and Aging Center, Department of Neurology, University of California, San Francisco, CA, USA.
Giselle M KnudsenAlaunus Biosciences, Inc, South San Francisco, CA, USA.
Emma L GundersonDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.
Angelica Sandoval-PerezDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.
Molly HodulMemory and Aging Center, Department of Neurology, University of California, San Francisco, CA, USA.
Kathryn BowlesDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, USA.
Charles S CraikDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.
Matthew P JacobsonDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.
Aimee W KaoMemory and Aging Center, Department of Neurology, University of California, San Francisco, CA, USA. aimee.kao@ucsf.edu.ORCID http://orcid.org/0000-0002-7686-7968
University of California, San Francisco · USCoherus BioSciences (United States) · USUK Dementia Research Institute · GBUniversity Memory and Aging Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37254128
PMCPMC10228009
OpenAlexW4378782239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.